Latest stories on TLX
Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference
Business Insider56 · neutralgeneral
TLX Stock Clocks 5% Gain This Week Ahead Of FDA Decision On Brain Cancer Imaging Agent
Stocktwits News63 · neutralproduct/pr
Telix Pharmaceuticals Shares Rise 5.3% as Analyst Highlights BiPASS Trial and FDA Pathway
InvestorsHub64 · neutralproduct/pr
Why is Telix Pharmaceuticals stock rallying today?
Investing.com Markets50 · neutralgeneral
Telix Pharmaceuticals stock jumps on trial completion, FDA path
Investing.com Markets67 · bullishproduct/pr
H.C. Wainwright reiterates Telix Pharmaceuticals stock rating on trial completion
Investing.com Analyst Ratings56 · neutralanalyst
Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway
StockTitan63 · neutralproduct/pr
Telix Pharmaceuticals: Execution Is The Name Of The Game Here
Seeking Alpha63 · neutralproduct/pr
Telix Pharmaceuticals Limited Q2 2026 Earnings Call Summary
Yahoo Finance50 · neutralearnings
Telix Pharmaceuticals reports 1H results
Seeking Alpha63 · neutralearnings
Telix Delivers Robust Revenue Growth and Pipeline Momentum: H1 2026 Results Spotlight Commercial and R&D Strength
August 20, 2026
MarketChameleon73 · bullishearnings
Telix Pharmaceuticals Limited (TLX) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Telix Pharmaceuticals Limited 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Telix Pharmaceuticals H1 Earnings Call Highlights
Yahoo Finance73 · bullishearnings
Telix Pharmaceuticals: The Radiopharma Operating System Is The Real Moat
Seeking Alpha67 · bullishanalyst
Telix H1 2026 Results: Investor Webcast Notification
Business Insider50 · neutralgeneral
Telix H1 2026 Results: Investor Webcast Notification
StockTitan50 · neutralgeneral
Telix Pharmaceuticals reports Q2 results; updates FY2026 outlook
Seeking Alpha67 · bullishearnings
Why is Telix Pharmaceuticals stock climbing today?
Investing.com Markets50 · neutralgeneral
Telix Q2 Revenue US$247M, Strong Momentum and Pipeline Progress
Business Insider67 · bullishearnings
Telix Q2 Revenue US$247M, Strong Momentum and Pipeline Progress
StockTitan67 · bullishearnings
FDA Alignment to Advance ProstACT Global Phase 3 Trial | TLX Stock News
StockTitan63 · neutralproduct/pr
Telix Pharmaceuticals Limited (TLX) Discusses Neurologic Oncology Portfolio and Advances in Therapeutic and Diagnostic Agents - Slideshow
Seeking Alpha55 · neutralproduct/pr
Telix Pharmaceuticals Limited (TLX) Discusses Neurologic Oncology Portfolio and Advances in Therapeutic and Diagnostic Agents Transcript
Seeking Alpha56 · neutralproduct/pr